Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS41003 (Octenidine/Prednicarbate) in Intertriginous Candida Infections
NCT01102387Phase 2Completed
- Sponsor
- Almirall
- Start
- Feb 2010
- Primary completion
- Jul 2011
- Modality
- Lipid-based Nanoparticles, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of octenidine, prednicarbate in candidiasis, sponsored by Almirall. Started Feb 2010; status: completed.
02
Drugs
octenidineprednicarbate
03
Conditions
candidiasis
Beyond the preview
Go deeper on NCT01102387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01102387.